Ková cs, Gergely, Já nos Peti-Peterdi, Lá szló Rosivall, and P. Darwin Bell. Angiotensin II directly stimulates macula densa Na-2Cl-K cotransport via apical AT1 receptors. Ϫ6 M failed to stimulate the cotransporter, whereas increased cotransport activity could be restored by blocking AT 2 receptors with PD-123, 319. Thus ANG II may modulate TGF responses via alterations in MD Na-2Cl-K cotransport activity. furosemide; tubuloglomerular feedback; angiotensin receptor blockade; cytosolic sodium concentration; fluorescent microscopy MACULA DENSA (MD) CELLS OF the distal nephron are the sensor elements of tubuloglomerular feedback (TGF), a mechanism that plays a major role in the regulation of glomerular filtration and renal hemodynamics (4, 34). These cells detect changes in luminal fluid NaCl concentration ([NaCl] L ), in part, through a furosemidesensitive apical Na-2Cl-K cotransporter (NKCC) (4, 18, 22, 24, 33) . MD cells then send signals (40), which alter both afferent arteriolar resistance (TGF) and the release of renin. Previous work has shown the importance of MD NKCC activity in both TGF and renin release, because blockade of this apical ion transport process with furosemide abolishes TGF responses and markedly increases the rate of renin release (15, 39).
MACULA DENSA (MD) CELLS OF the distal nephron are the sensor elements of tubuloglomerular feedback (TGF), a mechanism that plays a major role in the regulation of glomerular filtration and renal hemodynamics (4, 34) . These cells detect changes in luminal fluid NaCl concentration ([NaCl] L ), in part, through a furosemidesensitive apical Na-2Cl-K cotransporter (NKCC) (4, 18, 22, 24, 33) . MD cells then send signals (40) , which alter both afferent arteriolar resistance (TGF) and the release of renin. Previous work has shown the importance of MD NKCC activity in both TGF and renin release, because blockade of this apical ion transport process with furosemide abolishes TGF responses and markedly increases the rate of renin release (15, 39) .
The vasoconstrictor hormone ANG II is generally considered to be a specific modulator of TGF (21) , because it enhances feedback responses to a given [NaCl] L . It also has been shown to stimulate electrolyte transport processes in many tubular segments, including the thick ascending limb (TAL) and proximal tubule (6, 10, 29) . At the present time, the site(s) at which ANG II interacts with the TGF signal transmission process remain(s) unknown. Although there are clearly AT 1 receptors located in renal arterioles and mesangial cells (26) , recent work established the existence of AT 1 receptors in MD cells (11) . This has opened up the possibility that ANG II could have effects on MD cell function that might lead to enhanced TGF responses. Indeed, recent work from our laboratory found that ANG II upregulates both MD apical (NHE2) and basolateral (NHE4) Na ϩ /H ϩ exchanger activities (6, 9, 29, 30) .
Because of the central role that NKCC plays in MD cell signaling, we sought to determine whether ANG II might also upregulate apical NKCC in MD cells. Because significant levels of ANG II have been detected in renal tubular fluid and MD cells also possess ANG II receptors at the apical membrane (7), the present study focused on the luminal actions of ANG II. NKCC activity was assessed by measuring intracellular Na 
METHODS

MD preparation.
We isolated and perfused cortical TALs (cTALs) with attached glomeruli, dissected from rabbit kidney as described earlier (27) (28) (29) (30) . Briefly, individual cTALs with attached glomeruli were manually dissected from sagittal slices of kidneys obtained from New Zealand White rabbits weighing 0.5-1 kg. The dissection solution was an isosmotic, low-NaCl Ringer solution composed of (in mM) 25 NaCl, 125 N-methyl-D-glucamine, 125 cyclamic acid, 5 KCl, 1 MgSO 4, 1.6 Na2HPO4, 0.4 NaH2PO4, 1.5 CaCl2, 5 D-glucose, and 10 HEPES for buffering, at 4°C. Individual preparations were transferred to a thermoregulated Lucite chamber mounted on a Leitz Fluovert inverted microscope and bathed in a modified Ringer solution (composition the same as above, except that 150 mM NaCl replaces N-methyl-D-glucamine, and cyclamate). The cTAL was cannulated and perfused with the low-NaCl Ringer solution. Both perfusate and bath solutions were bubbled with 100% O 2, pH was adjusted to 7.4, and the bath temperature was maintained at 38°C. This preparation contained the otherwise inaccessible MD cells and allowed us to manipulate the composition of the tubular fluid at the apical side (perfusate) independently from the basolateral side (bath).
[Na ϩ ]i measurement. [Na ϩ ]i of MD cells was measured by fluorescent microscopy and SBFI (Teflabs, Austin, TX), using techniques similar to that described for Ca 2ϩ and intracellular pH measurements (27, 28, 30) . SBFI fluorescence was measured at an emission wavelength of 510 nm in response to excitation wavelengths of 340 and 380 nm. Cells were loaded with the dye by adding SBFI-acetoxymethyl ester (AM; 20 M), dissolved in DMSO, to the luminal perfusate. The nonionic surfactant Pluronic F-127 was added (50 mg/ ml) to DMSO to facilitate loading that required ϳ15 min. Luminal SBFI-AM was removed when counts for each wavelength exceeded 2 ϫ 10 5 counts/s. Fifteen minutes were then allowed to elapse to ensure conversion to the free SBFI form and to allow fluorescence intensities at both wavelengths to stabilize. SBFI fluorescence ratios (340/380 nm) were converted into [ Statistical analysis. Data are expressed as means Ϯ SE. Statistical significance was tested using ANOVA. Significance was accepted at P Ͻ 0.05.
RESULTS
Basal and [NaCl] L -dependent [Na
, in the presence of 25 mM NaCl in the perfusate and 150 mM NaCl in the bath, averaged 27.7 Ϯ 1.05 mM (n ϭ 138). As exemplified in a representative recording in Fig. 1 and summarized in Fig. 2 , increasing [NaCl] L from 25 to 150 mM caused a rapid and sustained increase in [Na ϩ ] i by 18.5 Ϯ 1.14 mM (n ϭ 17), with a ⌬[Na ϩ ] i /⌬t of 5.54 Ϯ 0.53 ϫ 10 Ϫ4 U/s. This response was highly sensitive to the Na-2Cl-K cotransport blocker furosemide, which was added to the lumi- Ϫ12 M ANG II. These findings suggest that, at low, physiological concentrations of ANG II, MD Na-2Cl-K cotransport activity is stimulated via AT 1 receptors but that high levels of ANG II may also activate an AT 2 -mediated inhibitory pathway.
Effects of AT 2 agonist CGP-42112A. To test our hypothesis that high-dose ANG II (10 Ϫ6 M) activates both AT 1 and AT 2 receptors and that AT 2 receptors antagonize the stimulation of Na-2Cl-K cotransport activity by AT 1 receptors, we used CGP-42112A, an AT 2 -receptor agonist. As shown in Fig. 5 , when 10 nM CGP-42112A was administered alone into the lumen, there was no change in the initial rate of increase in MD [Na ϩ ] i when [NaCl] L was elevated. Coadministration of this AT 2 -receptor agonist with low-dose ANG II completely abolished the stimulatory effects of ANG II on ⌬[Na ϩ I ]/⌬t, whereas there was no effect of CGP-42112A in the presence of a high concentration of ANG II.
DISCUSSION
Previous studies have established that ANG II is an important and specific modulator of TGF (13, 21, 35, 36) . Mitchell and Navar (21) reported that peritubular capillary infusions of ANG I or ANG II augmented TGF responses as assessed by orthograde microperfusion and stop-flow pressure measurements. Schnermann and Briggs (35) found that ANG II was able to restore TGF feedback responses that were suppressed by prior volume expansion. Recently, Schnermann and coworkers (36) found that feedback responses were markedly suppressed in an AT 1A receptor-deficient mouse. Finally, Huang et al. (13) suggested that the effects of modulation of TGF responses by ANG II may be independent of the vasoconstrictive properties of Fig. 3 . Dose-dependent effects of ANG II on Na-2Cl-K cotransport activity in the absence/presence of luminal furosemide. The most effective ANG II concentrations were in the 10 Ϫ12 M range. Values are means Ϯ SE; n ϭ 17, 6, 7, 6, 14, 7, 13, and 6. ns, Nonsignificant compared with appropriate control group.*P Ͻ 0.05 compared with the appropriate control group. this hormone. This latter finding, coupled with the recent report of AT 1 receptors in MD cells (11) , makes it attractive to speculate that ANG II may have a modulator role in TGF at the level of the MD.
In this regard, we have recently shown that both NHE2 and NHE4 activities in MD cells are stimulated by physiological concentrations of ANG II via AT 1 receptors located at both apical and basolateral cell membranes (6, 29) . Whether this stimulation of Na ϩ /H ϩ exchange by ANG II plays a role in TGF signaling or in modulating TGF responsiveness is, as yet, unknown. What is known, however, is the important role that the Na-2Cl-K cotransporter plays in MD cell signaling. TGF responses are clearly inhibited by loop diuretics that block this cotransporter (39) . Thus it was logical to ask the question of whether ANG II stimulates the apical Na-2Cl-K cotransporter in MD cells (4, 20, 33) .
These studies used the fluorescent Na-sensitive probe SBFI in the isolated perfused MD preparation. (28) that demonstrated a high rate of Na-2Cl-K cotransport activity in MD cells but less efficient Na ϩ efflux. Na ϩ reabsorption in MD occurs through the apical Na-2Cl-K cotransporter and NHE2 (4, 20) . Under steady-state conditions where lumen and bath [NaCl] were constant, luminal ANG II produced a significant increase in MD resting [Na ϩ ] i . Similarly, luminal ANG II greatly stimulated the increase in MD [Na ϩ ] i in response to elevations in [NaCl] L . These effects were sensitive to luminal furosemide, clearly indicating stimulation of the MD Na2Cl-K cotransport activity by ANG II. Also, luminal ANG II still tended to have a small effect on MD Na ϩ dynamics even in the presence of furosemide, which is consistent with the previously published stimulatory effect of ANG II on MD NHE2 activity (29) . We estimate that ϳ80% of Na ϩ entry occurs via the cotransporter, whereas most of the remaining Na ϩ entry is through Na ϩ /H ϩ exchange. Because the stimulatory effect of ANG II on TGF responses was shown with systemic or peritubular administration of ANG II, we also investigated the effect of basolateral ANG II on apical Na-2Cl-K cotransport activity. We found no difference between apical and basolateral addition of ANG II and no additive effect when ANG II was simultaneously added to both sides of MD cells. These findings, along with previous results from our laboratory (29) , suggest a common intracellular signaling pathway of ANG II for either apically or basolaterally located AT receptors.
We found that nanomolar-to-picomolar luminal ANG II stimulated MD NKCC activity, whereas micromolar ANG II failed to alter cotransport activity. This biphasic effect of ANG II appears to be a general phenomenon and has also been described for NKCC activity in TAL (2) and several NHE activities along the nephron (10, 29, 32) . Nearly all previous studies have focused on the effects of ANG II on the other main NKCC isoform (NKCC1), which is found in nonpolar cells and at the basolateral membrane in certain polarized epithelial cells. In mesangial cells (11) , vascular smooth muscle cells (1, 25, 37) , and endothelial cells (23) , there is, generally, a dose-and time-dependent stimulation of NKCC1 by ANG II. We are aware of only one study (2) concerning the regulation of NKCC2 in renal tubular epithelial cells by ANG II. Amlal et al. demonstrated, using the NH 4 ϩ technique, that low-dose ANG II inhibited, whereas high-dose ANG II stimulated, the apical Na-2Cl-K cotransporter in medullary TAL via AT 1 receptors. However, as indicated previously, the NH 4 ϩ technique is problematic in studies of this nature due to the effects of ANG II on Na ϩ /H ϩ exchange. Thus our studies are consistent with those obtained for the NKCC1 isoform, where low-dose ANG II stimulates cotransport activity.
Coadministration of candesartan with ANG II clearly inhibited the stimulatory effects of 10 Ϫ9 M luminal ANG II, suggesting an AT 1 receptor-mediated response. Interestingly, coadministration of PD-123, 319 with high-dose (10 Ϫ6 M) luminal ANG II restored the stimulatory effects of ANG II to the level observed with 10 Ϫ12 M luminal ANG II. This finding suggests that other, inhibitory ANG II receptor subtypes (AT 2 ) are involved in the overall ANG II response in MD cells. In addition, it would appear that this inhibitory pathway is activated, or its activity is manifested, only at high concentrations of ANG II. At the present time, this is a little puzzling because, as reviewed by Ardalliou (3), both AT 1 and AT 2 receptors appear to have similar affinities for ANG II (IC 50 ϳ1 nM). Also, we found that administration of an AT 2 -receptor agonist blocked the effects of 1 nM luminal ANG II on cotransport activity, further supporting an inhibitory role for AT 2 receptors in MD cells. On the other hand, it is also possible that there are receptor-independent effects of ANG II on cell function, especially at high micromolar concentrations of this hormone.
The present paradigm has been that, as ANG II levels increase, there is an AT 1 receptor-mediated, concentration-dependent activation of various cell-signaling pathways. Recent studies (10, 12, 23, 37) suggest that ANG II receptors can be coupled to a number of signal transduction pathways, including adenylate cyclase, protein kinases A and C, phospholipase C and A 2 , cytosolic Ca 2ϩ system, and P-450-arachidonic acid metabolites. This progressive recruitment of signal transduction pathways has been one means of explaining the biphasic effects of ANG II. We speculate that, in MD cells, there may also be a concentration-dependent activation of different AT receptors and that this may also contribute to the biphasic actions of ANG II.
The role of AT 2 receptors in the adult has been difficult to ascertain, but it is generally reported (8) that activation of the AT 2 receptor opposes the actions of the AT 1 receptor. Our results may be another example whereby AT 2 receptors function in a manner that is opposite to the actions of the AT 1 receptor. Interestingly, Carey et al. (8) have reported that at least some of the effects of AT 2 receptor activation may be mediated by the nitric oxide (NO) system. In this regard, MD cells have a high level of calcium dependent-neuronal NO synthase (nNOS) expression (38) . Thus it is plausible that high concentrations of ANG II cause MD cell calcium to rise, thereby activating calcium sensitive-nNOS and the generation of NO, although this has not yet been tested experimentally. Recently, Plato et al. (31) reported that NO production inhibits cotransport activity in the TAL. However, extensive studies will be required to further characterize the signaling pathways mediating the effects of AT 1 and AT 2 receptor activation on MD NKCC activity.
In summary, both luminal and basolateral ANG II, in the nanomolar range, stimulated MD Na-2Cl-K cotransport. This effect of luminal ANG II on cotransport activity occurred via activation of AT 1 receptors at the apical membrane. At higher concentrations (10 Ϫ6 M), ANG II did not stimulate cotransport activity, most likely because of the opposing actions of apical AT 2 receptors. Thus ANG II modulation of TGF responses at the MD may occur through AT receptor alterations in Na-2Cl-K cotransport.
